Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
批准号:
8484427
负责人:
NELSON RUIZ-OPAZO
金额:
$38.29万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-20 至 2015-06-30
关键词:
AddressAgeAnimal ModelArteriesBlood PressureCardiovascular DiseasesCardiovascular systemCarotid ArteriesChronic Kidney FailureClinical ResearchCollagenCoronary heart diseaseDataDevelopmentDiseaseElastinEnvironmentEpigenetic ProcessEssential HypertensionEtiologyFemaleGene ExpressionGenesGeneticGenetic Predisposition to DiseaseGoalsHousingHypertensionImplantInterventionInvestigationLeadLifeMeasurementMeasuresModelingMolecularMolecular GeneticsMonitorOrganOutcomePathway interactionsPhysiologic pulsePlayPredispositionPrevention strategyQuantitative Trait LociRattusResearchResearch ProposalsResistanceResolutionRiskRoleSodium ChlorideStrokeStructureSusceptibility GeneSystemTestingTimeTransgenic OrganismsUltrasonographyWorkarterial stiffnessexperiencegene environment interactiongenetic linkage analysisgenetic variantgenome wide association studygenome-wide linkageinsightmalemeetingsminiaturizenanonew technologypublic health relevancesalt sensitivesexsystems researchtrait
中文摘要
描述(由申请人提供):我们的长期目标是阐明原发性或多基因高血压的病因学,重点是阐明高血压易感性和基因-环境相互作用的遗传变异,这些变异会加剧高血压易感性和终末器官疾病。在临床研究中,以脉搏波速度或PWV测量动脉硬化的重要性日益显现,表明PWV增加与心血管结果(中风、冠心病和慢性肾病)相关,这可能是一个可靠的预测参数,但同时也强调了动物模型研究的必要性,以解决机制问题。因此,本研究计划侧重于rfa声明的目标:#1)“在动物模型中探索动脉硬化与高血压发展之间的时间关系”,#2)进行“在(原发性/多基因)高血压背景下导致导管动脉硬化的机制的细胞和分子研究”。为实现这一目标,我们确定了以下优先目标:研究雄性和雌性中风易感达尔S大鼠大动脉硬化(通过高分辨率超声测量主动脉PWV和应变,颈动脉PWV和应变)和盐敏感性高血压(通过无应激24/7收缩压、舒张压、MAP和PP遥测血压分析测量)与中风的时间关系。目标2。明确所有三个血管层主动脉和颈动脉结构的时间和空间变化,以及推定的基因表达变化,这些变化是na诱导的高血压及其终器官并发症病程中动脉僵硬加剧和进展的基础。目标3。通过对F2杂交雄性和雌性大鼠的全基因组扫描,阐明在多基因盐敏感性高血压背景下动脉僵硬的遗传机制的作用,鉴定单独或相互作用导致动脉僵硬的共同和性别特异性数量性状位点(qtl)。总之,这三个目的将阐明在na诱导的卒中易发高血压大鼠模型中,主动脉和颈动脉僵硬与多基因(原发性)高血压和卒中的关系,并深入了解因果细胞、分子和遗传机制。
英文摘要
DESCRIPTION (provided by applicant): Our long term goal is to elucidate the etiology of essential or polygenic hypertension with a focus on the elucidation of genetic variants that underlie hypertension susceptibility and gene-environment interactions which exacerbate hypertension susceptibility and end-organ disease. The emerging importance of arterial stiffening measured as pulse wave velocity or PWV in clinical studies demonstrating the association of increased PWV and cardiovascular outcomes (stroke, coronary heart disease, and chronic kidney disease) has pinpointed a likely robust predictive parameter, but at the same time highlighted the need for animal model studies to address mechanisms. Accordingly, this research proposal focuses on RFA-stated goals: #1) "to explore the temporal relationship between arterial stiffening and the development of hypertension in an animal model", and #2) to conduct "cellular and molecular investigation of mechanisms that lead to conduit artery stiffening in the context of (essential/polygenic) hypertension". To accomplish this we have prioritized the following specific aims: Aim 1. Examine the temporal relation between large artery stiffening (measured as aortic PWV and strain, carotid PWV and strain via high-resolution ultrasonography), and the development of salt-sensitive hypertension (measured via non-stress 24/7 telemetric BP analysis of SBP, DBP, MAP and PP) and stroke in both male and female stroke-prone Dahl S rats. Aim 2. Define the temporal and spatial changes in aortic and carotid artery structure in all three vessel layers, along with putative gene expression changes that underlie Na-induced exacerbation and progression of arterial stiffness along the disease course of hypertension and its end-organ complications. Aim 3. Elucidate the role of genetic mechanisms in the causation of arterial stiffness in the context of polygenic salt-sensitive hypertension via genome-wide scan of F2[Dahl S x Dahl R]-intercross male and female rats identifying common and sex-specific quantitative trait loci (QTLs) that contribute to arterial stiffness individually or interactively. Altogether, these three aims will elucidate the relationship of aortic and carotid arterial stiffness to polygenic (essential) hypertension and stroke in a Na-induced stroke-prone hypertension rat model, as well as give insight into causal cellular, molecular, and genetic mechanisms.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Sex-specific genetic determinants for arterial stiffness in Dahl salt-sensitive hypertensive rats.
DAHL盐敏感高血压大鼠的动脉刚度的性别特异性遗传决定因素。
DOI:
10.1186/s12863-015-0324-7
发表时间:
2016-01-11
期刊:
BMC genetics
影响因子:
2.9
作者:
[Decano JL, Pasion KA, Black N, Giordano NJ, Herrera VL, Ruiz-Opazo N]
通讯作者:
Ruiz-Opazo N
DOI:
10.1371/journal.pone.0107888
发表时间:
2014
期刊:
PloS one
影响因子:
3.7
作者:
[Herrera VL, Decano JL, Giordano N, Moran AM, Ruiz-Opazo N]
通讯作者:
Ruiz-Opazo N
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
-
批准号:8015867
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2010
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
-
批准号:8145199
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2010
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
-
批准号:8292163
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2010
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Functional characterization of ATP1A1 and DEspR variants associated with essentia
-
批准号:7701362
-
项目类别:
-
资助金额:$36.56万
-
财政年份:2009
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Functional characterization of ATP1A1 and DEspR variants associated with essentia
-
批准号:7932877
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2009
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Gender-specific genetic determinants of hypertension and end organ disease
-
批准号:7461206
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2008
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Gender-specific genetic determinants of hypertension and end organ disease
-
批准号:7676110
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2008
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Gender-specific genetic determinants of hypertension and end organ disease
-
批准号:7888204
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2008
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Molecular Genetics of the ET-1/AngII Receptor
-
批准号:6459132
-
项目类别:
-
资助金额:$40.47万
-
财政年份:2002
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Molecular Genetics of the ET-1/AngII Receptor
-
批准号:6622909
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2002
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Molecular Genetics of the ET-1/AngII Receptor
-
批准号:6852637
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2002
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Molecular Genetics of the ET-1/AngII Receptor
-
批准号:6718412
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2002
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
SODIUM TRANSPORTER GENES AND ESSENTIAL HYPERTENSION
-
批准号:2467695
-
项目类别:
-
资助金额:$33.76万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Role of Na+ Transporter Genes in Essential Hypertension
-
批准号:6721144
-
项目类别:
-
资助金额:$32.6万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
SODIUM TRANSPORTER GENES AND ESSENTIAL HYPERTENSION
-
批准号:2857932
-
项目类别:
-
资助金额:$34.77万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
SODIUM TRANSPORTER GENES AND ESSENTIAL HYPERTENSION
-
批准号:6139249
-
项目类别:
-
资助金额:$35.82万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Role of Na+ Transporter Genes in Essential Hypertension
-
批准号:6855076
-
项目类别:
-
资助金额:$32.6万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Role of Na+ Transporter Genes in Essential Hypertension
-
批准号:6468775
-
项目类别:
-
资助金额:$32.6万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
ANG II AND AVP ISORECEPTORS IN BLOOD PRESSURE
-
批准号:6330161
-
项目类别:
-
资助金额:$31.36万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
ANG II AND AVP ISORECEPTORS IN BLOOD PRESSURE
-
批准号:6125874
-
项目类别:
-
资助金额:$29.66万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: